epigallocatechin gallate has been researched along with Liver Steatosis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Chu, L; Gao, F; Ji, B; Jia, G; Liu, J; Liu, Y; Wang, A; Wei, Y; Wu, W; Xie, L; Zhang, D; Zhou, F | 1 |
| Di Giacomo, M; Ferramosca, A; Zara, V | 1 |
| Dai, Z; Feng, S; Huang, J; Liu, A; Lu, W; Reuhl, K; Wang, H; Yang, CS | 1 |
| Bae, UJ; Chae, BM; Chae, SW; Jung, SJ; Oh, MR; Park, BH; Park, IW; Park, J; Ryu, GS | 1 |
| Fung, ML; Ho, CT; Lau, TY; Leung, TM; Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J | 1 |
| Baba, A; Kochi, T; Kubota, M; Moriwaki, H; Ohno, T; Shimizu, M; Shirakami, Y; Tanaka, T; Terakura, D; Tsurumi, H | 1 |
| Bay, BH; Farah, BL; Singh, BK; Sinha, RA; Wu, Y; Yang, CS; Yen, PM; Zhou, J | 1 |
| Chakrapani, LN; Durairajan, S; Ganesan, T; J, T; Krishnan, TR; Mangaiah, S; Narasimhan, K; Nathakattur Saravanabavan, S; Periandavan, K; Srinivasan, A; Velusamy, P; Walter, CE | 1 |
| Chan, YC; Chang, SJ; Liu, HW; Wang, MF; Wei, CC | 1 |
| Carnier, J; de Souza, GH; Lira, FS; Mennitti, LV; Oliveira, JL; Oller do Nascimento, CM; Oyama, LM; Ribeiro, EB; Santamarina, AB; Santana, AA; Silva, FP | 1 |
| Bose, M; Ju, J; Lambert, JD; Reuhl, KR; Shapses, SA; Yang, CS | 1 |
| Hashimoto, O; Inoue, K; Koga, H; Nakamura, T; Nakayama, H; Otabe, S; Sata, M; Sivakumar, R; Torimura, T; Ueno, T; Yamada, K; Yuan, X | 1 |
| Campbell, C; Chavin, KD; Cheng, G; Donovan, JL; Evans, Z; Fiorini, RN; Haines, JK; Markowitz, JS; May, HD; Milliken, CE; Rodwell, D; Schmidt, MG | 1 |
| Bahcecioglu, IH; Dagli, AF; Kuzu, N; Ozercan, IH; Sahin, K; Ustündag, B | 1 |
1 review(s) available for epigallocatechin gallate and Liver Steatosis
| Article | Year |
|---|---|
Antioxidant dietary approach in treatment of fatty liver: New insights and updates.
Topics: Animals; Anthocyanins; Antioxidants; Carotenoids; Catechin; Coumestrol; Curcumin; Energy Metabolism; Fatty Liver; Glucosinolates; Humans; Imidoesters; Isothiocyanates; Lipogenesis; Mitochondria; Non-alcoholic Fatty Liver Disease; Nutritional Sciences; Oxidative Stress; Oximes; Polyphenols; Quercetin; Resveratrol; Stilbenes; Sulfoxides; Xanthophylls | 2017 |
13 other study(ies) available for epigallocatechin gallate and Liver Steatosis
| Article | Year |
|---|---|
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
Topics: Antioxidants; Cell Line; Fatty Liver; Flavonoids; Humans; In Vitro Techniques; Oleic Acid; Reactive Oxygen Species; Triglycerides | 2011 |
Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice.
Topics: Adipose Tissue; Animals; Bile Acids and Salts; Blood Glucose; Catechin; Fatty Liver; Insulin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Tea | 2018 |
Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
Topics: Animals; Catechin; Cell Survival; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Obesity; Phytotherapy; Plant Extracts; Sirtuin 1; Tea; Weight Gain | 2018 |
Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catechin; Cyclooxygenase 2; Diet, High-Fat; Down-Regulation; Fatty Liver; Female; Fibrosis; Forkhead Transcription Factors; Inflammation; Liver; Matrix Metalloproteinase 2; Nerve Tissue Proteins; NF-kappa B; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Tumor Necrosis Factor-alpha | 2014 |
Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions.
Topics: Angiotensin II; Animals; Anticarcinogenic Agents; Catechin; Fatty Liver; Gene Expression; Hypertension; Interleukin-6; Lipid Peroxidation; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptidyl-Dipeptidase A; Precancerous Conditions; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Tumor Necrosis Factor-alpha | 2014 |
Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance.
Topics: Adenylate Kinase; Animals; Autophagy; Catechin; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Phagosomes; Tea | 2014 |
EGCG mediated downregulation of NF-AT and macrophage infiltration in experimental hepatic steatosis.
Topics: Animals; Antioxidants; Catechin; Cell Adhesion Molecules; Cholesterol, Dietary; Down-Regulation; Drug Evaluation, Preclinical; Fatty Liver; Liver; Macrophages; Male; NF-kappa B; NFATC Transcription Factors; Phytotherapy; Plant Extracts; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |
Dietary (-)-Epigallocatechin-3-gallate Supplementation Counteracts Aging-Associated Skeletal Muscle Insulin Resistance and Fatty Liver in Senescence-Accelerated Mouse.
Topics: Aging; Animals; Camellia sinensis; Catechin; Dietary Supplements; Fatty Liver; Female; Glucose; Glucose Transporter Type 4; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Muscle, Skeletal; Plant Extracts; Sterol Regulatory Element Binding Protein 1 | 2015 |
Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High-Fat Diet.
Topics: AMP-Activated Protein Kinases; Animals; Blotting, Western; Body Weight; Catechin; Diet, High-Fat; Enzyme Activation; Fatty Liver; Male; Mice; Plant Extracts; Protein Serine-Threonine Kinases; Tea | 2015 |
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.
Topics: Adipose Tissue; Animals; Biomarkers; Body Weight; Catechin; Diet; Dietary Fats; Eating; Fatty Liver; Feces; Lipids; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Tea | 2008 |
Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adipose Tissue; Animals; Catechin; Deoxyguanosine; Fatty Liver; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Mice; Mice, Transgenic; Sterol Regulatory Element Binding Protein 1 | 2009 |
Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Topics: Animals; Antioxidants; Body Weight; Catechin; Disease Models, Animal; Energy Intake; Energy Metabolism; Fatty Liver; Hepatocytes; Liver; Liver Circulation; Male; Mice; Mice, Obese; Necrosis; Reperfusion Injury | 2005 |
Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet.
Topics: Animals; Antioxidants; Catechin; Diet; Dietary Fats; Disease Models, Animal; Fatty Liver; Liver; Male; Rats; Rats, Sprague-Dawley | 2008 |